Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49)

Clinical guideline · Tier 1, UK official · UK · 2016-07-06, updated 2026-07-31

Under review — checked with the publisher on 2026-09-01

https://www.nice.org.uk/guidance/ng49

What this platform has drawn from it — 1 claim

In July 2026 NICE renamed and updated its guideline to reflect that MASLD is the new name for non-alcoholic fatty liver disease and MASH is the new name for non-alcoholic steatohepatitis. Overview, Update information
read on Cirrhosis

How this record was checked, and what is doubtful about it

RESOLVES THE UK NOMENCLATURE QUESTION AT TIER 1. Published 06 July 2016; renamed and updated 31 July 2026 - five weeks before this search. NICE states plainly that MASLD is the new name for NAFLD and MASH the new name for NASH. Status recorded as under_review because NICE states on the page that it has checked the guideline and is updating it, with a guideline-in-development page tracking progress.

Verification: verified · last accessed 2026-09-01 · status checked against https://www.nice.org.uk/guidance/ng49